Science
for Sale: The Perils, Rewards, and
Delusions of Campus Capitalism
by Daniel S. Greenberg
University of Chicago Press, Chicago,
IL, 2007
288 pp., Paper, $ 25.00
ISBN: 10: 0-226-30625-9.
Reviewed by Wilfred Niels Arnold
University of Kansas Medical Center
warnold@kumc.edu
“Sale,” “reward” and “capitalism” were
decidedly antithetical to the mores of academic science 50 years ago. Rather,
in those days it was engraved in stone that aspirants to professorial careers “must
be committed to advancing the field” but should not expect “personal
financial reward.”
To their credit, most American universities continue to expect the undergraduate
students themselves or the state to meet the costs of formal instruction. But
over the last several decades their departments, especially those that play
in the “hard”
sciences, have increasingly sought federal support for basic research activities
including the stipends of graduate students and postdoctorals. There was a relatively short period during
which this relationship seemed to work smoothly because of a marvellous font
of running money. Although unimaginable
today, comments from senior professors during the years of our jingoistic
jealousy of Sputnik indicate that program directors of the National Institutes
of Health and the National Science Foundation were actually calling university
professors to urge submission of research grant applications.
Spurred on by deans of research, the academic institutions as well as individual
investigators became addicted to federal money. This pleased and relieved state politicians,
but the inevitable competition among schools, cities, and states became brisk. [National
ranking lists on grant-winning are now commonplace.] More importantly, a silly corollary surfaced, i.e. that any
research idea worth its salt must surely be able to attract grant support. An even bigger intellectual insult coupled
the inability to get funding with “being in the wrong field, chasing
the wrong rainbow, or simply not thinking along the right lines.” Promotion, tenure, and survival became
intimately connected to grantsmanship. On
the other hand, in all but the best universities promotions are now assured
by threats of leaving home and taking research grants to other schools. A funny variation finds disgruntled individuals
moving within the same university because the grant that travels with them
is welcomed by a local department that happens to be short on grants at the
moment. And the administrators
are apparently comfortable with this zero-sum game!
Much of the above is revealed en passant in Science
For Sale, but Greenberg’s present
focus for analysis and criticism is the Bayh-Dole Act, also known as the
University and small business patent procedures act. He exposes its effects on the climate
and goals of science in this country. This
legislation was sponsored by senators Birch Bayh of Indiana and Bob Dole
of Kansas. It was enacted by
the U.S. Congress on December 12, 1980. The
act permits a university, small business, or non-profit institution to pursue
ownership of an invention before or instead of the government, even though
the government has sponsored the salient research. In a gesture to the taxpayers, Bayh-Dole
provided the government with a royalty-free license to the patents, which
has turned out to be a very rarely exercised option according to Greenberg. The
take-home message is that government agencies want to nurture the translation
of research results into potentially saleable products. Also,
politicians want tangible results.
Chapter 3, provocatively entitled “Commercialize! It’s the
Law” and the Epigraph is taken directly from the Bayh-Dole
Act: “It is the policy and objective of the Congress to use the patent
system to promote the utilization of inventions arising from federally
supported research development … [and] to promote collaboration
between commercial concerns and nonprofit organizations, including universities.” Greenberg notes that “the bill
directed universities to conduct their patent dealings with small business
firms, a dual sop to populist sentiments and the presence of small business
in every congressional district. Three
years later, the small business preference was removed from the act in
recognition of the fact that conventional small businesses lack the talent
and resources to transform scientific knowledge into a saleable product. However, involvement for small business
later developed on its own with the proliferation of biotech spin-offs
from academic research.”
Who was surprised that Bayh-Dole led to a new breed of scientist-entrepreneur
and spin-off companies! It
also influenced the selection of research subjects to be investigated. Patent applications by professors started
being counted as publications.
Greenberg takes the reader down the tortuous experiences of eager universities
and principal investigators who seek corporate funding in order to facilitate
the translation of basic research into products and then become conscious
of attached strings. He cannot
be accused of dodging the issues. This
book has the structure and argument we associate with the best in sociology
of science. Recently I heard
myself remark that it’s a hard book to read––not because
of the writing but because the message will be more than challenging to
concerned readers.
Science For Sale is divided into three
parts. The first, “The Setting
and the System” includes “The price of profits” (chapter
5) and “Conflicts of interest” (chapter 6). The
second part, “As seen from the inside––six conversations” presents
a balanced evaluation based on interviews, with chapters such as “Success
and Remorse”(chapter 8), “A Congenial Partnership,” (chapter
9) and “The [Scientific] Journals Revolt.” (chapter 13). Part three, “Fixing the System” makes a brave
attempt to offer help. It ends
with an admirable “Parable of our Time” in which Greenberg brings
back Dr. Grant Swinger [see “The Grant Swinger Papers,” 32 pages,
1981, University of California Press] in an entertaining combination of humorous
extremes and painful realities. A
small collection of notes is assembled for each chapter. There is a useful index that works.
Daniel S. Greenberg (b. 1931) is a veteran science reporter with a distinguished
career as a commentator upon science and health politics. His position has been lonely because
few have the courage to analyze, let alone criticize, the sacred cows that
fund scientific enquiry in the U.S. The
Library of Congress lists six items under his name. They include “The Politics of Pure Science,” (1999)
and
“Science Money and Politics,” (2001).